Pricing

ALTIUM CAPITAL MANAGEMENT LP

1 follower ยท
NEW YORK NY
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Altium Capital Management is based out of New York. Their last reported 13F filing for Q2 2024 included $245,120,808 in managed 13F securities and a top 10 holdings concentration of 55.89%. Altium Capital Management's largest holding is Vera Therapeutics Inc with shares held of 714,000. Whalewisdom has at least 17 13F filings, and 162 13G filings

2024-06-30

Top Buys (13F)

Name % Change
SRPT Sarepta Therapeutics 5.28%
SKYE Skye Bioscience Inc 4.41%
ARGX Argenx SE ADS ADR 4.04%
INSM Insmed Inc 3.9%
CTNM Contineum Therapeuti 3.08%

2024-06-30

Top Sells (13F)

2024-06-30

13F Holdings Summary

Name $ Change
VERA Vera Therapeutics In 10.54%
ADMA ADMA Biologics Inc 6.89%
XENE Xenon Pharmaceutical 5.74%
ITCI Intra-Cellular Thera 5.39%
SRPT Sarepta Therapeutics 5.28%

2024-06-30

13F Activity

Market Value $245m, Prior: $253m
Inflows (Outflows) as % of Total MV +2.9286%
New Purchases 18 stocks
Added To 14 stocks
Sold out of 22 stocks
Reduced holdings in 12 stocks
Top 10 Holdings % 55.89%
Turnover %[1] 44.44%
Turnover Alt %[2] 35.84%
Time Held Top 20 1.5 quarters
Time Held Top 10 0.8 quarters
Time Held All 3.32 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-06-30

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2024-06-30

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30

Portfolio Performance